Literature DB >> 20347867

The diagnostic role of procalcitonin and other biomarkers in discriminating infectious from non-infectious fever.

M Limper1, M D de Kruif, A J Duits, D P M Brandjes, E C M van Gorp.   

Abstract

Fever is not only observed in the course of a bacterial or viral infection, but can be a symptom of, for instance, auto-immune, malignant or thromboembolic disease. Determining the etiology of fever in a fast and reliable way is of pivotal importance, as different causes of fever may ask for different therapies. Neither clinical signs and symptoms, nor traditional biomarkers, such as CRP, leukocytes and ESR have sufficient sensitivity and specificity to guide treatment decisions. In this review we focus on the value of traditional and newer biomarkers in non-infectious febrile diseases. Procalcitonin (PCT) seems to be the most helpful laboratory marker for the differentiation of causes of fever, particularly in autoimmune, autoinflammatory and malignant diseases. Copyright (c) 2010 The British Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20347867     DOI: 10.1016/j.jinf.2010.03.016

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  53 in total

Review 1.  Are there new approaches for diagnosis, therapy guidance and outcome prediction of sepsis?

Authors:  Dubravka Kojic; Benedikt H Siegler; Florian Uhle; Christoph Lichtenstern; Peter P Nawroth; Markus A Weigand; Stefan Hofer; Thorsten Brenner
Journal:  World J Exp Med       Date:  2015-05-20

2.  Early monitoring of ventriculostomy-related infections with procalcitonin in patients with ventricular drains.

Authors:  Amr S Omar; Amr ElShawarby; Rajvir Singh
Journal:  J Clin Monit Comput       Date:  2015-02-01       Impact factor: 2.502

3.  The role of procalcitonin in respiratory infections.

Authors:  Laura Certain; Philipp Schuetz
Journal:  Curr Infect Dis Rep       Date:  2012-06       Impact factor: 3.725

4.  Serum hsCRP and procalcitonin levels in dyspeptic patients infected with CagA-positive Helicobacter pylori.

Authors:  Bulur Oktay; Yeniova Abdullah Ozgur; Kucukazman Metin; Ata Naim; Asilturk Zeliha; Yıldız Mehmet; Kefeli Ayse; Basyigit Sebahat; Aktas Bora; Nazlıgul Yasar
Journal:  J Clin Lab Anal       Date:  2014-08-17       Impact factor: 2.352

5.  Diagnostic and prognostic value of procalcitonin levels in patients with Bell's palsy.

Authors:  Saffet Kilicaslan; Sinan Uluyol; Mehmet Hafit Gur; Ilker Burak Arslan; Ozlem Yagiz
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-19       Impact factor: 2.503

Review 6.  [Rheumatic patients in the intensive care unit].

Authors:  P Lehmann; T Brünnler; B Salzberger; M Fleck
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02-02       Impact factor: 0.840

7.  Diagnostic performance of procalcitonin, presepsin, and C-reactive protein in patients with hematological malignancies.

Authors:  Yasuhiro Ebihara; Kiyoko Kobayashi; Akaru Ishida; Tomoya Maeda; Naoki Takahashi; Yoshitada Taji; Norio Asou; Kenji Ikebuchi
Journal:  J Clin Lab Anal       Date:  2017-01-30       Impact factor: 2.352

8.  New approaches to sepsis: molecular diagnostics and biomarkers.

Authors:  Konrad Reinhart; Michael Bauer; Niels C Riedemann; Christiane S Hartog
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

Review 9.  Bacterial sepsis : Diagnostics and calculated antibiotic therapy.

Authors:  D C Richter; A Heininger; T Brenner; M Hochreiter; M Bernhard; J Briegel; S Dubler; B Grabein; A Hecker; W A Kruger; K Mayer; M W Pletz; D Storzinger; N Pinder; T Hoppe-Tichy; S Weiterer; S Zimmermann; A Brinkmann; M A Weigand; C Lichtenstern
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

10.  Anemia measurements to distinguish between viral and bacterial infections in the emergency department.

Authors:  Yael Steuerman; Asaf Wasserman; David Zeltser; Itzhak Shapira; Daniel Trotzky; Pinchas Halpern; Ahuva Meilik; Eli Raykhshtat; Shlomo Berliner; Ori Rogowski; Irit Gat-Viks; Shani Shenhar-Tsarfaty
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-09-06       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.